热消融治疗分化型甲状腺癌椎体转移可预防不良事件
单中心回顾性研究评估热消融治疗分化型甲状腺癌无症状椎体转移以预防椎体相关事件的策略。首次术后影像局部控制率87.8%,12和24个月分别为82.9%和75.6%;治疗椎体2年椎体相关事件率7.3%,首次影像达局部控制者显著低于未达者(0% vs 30%,p=0.011)。未治疗的19个新发椎体转移2年椎体相关事件率36.8%,显著高于治疗椎体(p=0.008)。
要点
- 热消融治疗分化型甲状腺癌椎体转移首次术后影像局部控制率87.8%,24个月降至75.6%。
- 首次术后影像达局部控制的治疗椎体2年椎体相关事件率为0%,未达者为30%。
- 未治疗的新发椎体转移2年椎体相关事件率36.8%,显著高于治疗椎体的7.3%。
核心结论
- 使用热消融实现椎体转移局部肿瘤控制可降低分化型甲状腺癌患者的椎体相关事件风险。
研究设计与样本
- 单中心回顾性研究,回顾所有接受热消融治疗无症状椎体转移的分化型甲状腺癌患者的记录和术后影像,共治疗28例患者的41个椎体转移。
诊断标准与关键数值
- 首次术后影像局部控制率87.8%,12个月82.9%,24个月75.6%。
- 治疗椎体2年椎体相关事件率7.3%。
- 首次术后影像达局部控制者2年椎体相关事件率0% vs 未达者30%(p=0.011,OR=0.184,95%CI=0.094-0.360)。
- 未治疗新发椎体转移2年椎体相关事件率36.8% vs 治疗椎体7.3%(p=0.008,OR=0.135,95%CI=0.030-0.607)。
临床应用与阅片要点
- 首次术后影像评估局部控制对预后判断有参考价值,未达局部控制的治疗椎体椎体相关事件风险更高。
- 随访中新出现且未追加热消融的椎体转移椎体相关事件风险较高。
局限性
- 本研究为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate a strategy that used thermal-ablation of vertebral metastases (VM) to prevent vertebral related events (VRE) in patients with differentiated thyroid cancer (DTC).
METHODS: This single center study retrospectively reviewed records and post-operative imaging of all DTC patients treated with thermal-ablation for asymptomatic VMs. Rate of local tumor control at first post-operative imaging, 12 and 24 months after thermal-ablation and rate of VREs at 12 and 24 months among the treated VMs were reported. New VMs that occurred during the follow-up and were not considered for additional thermal-ablation were moniroted and VREs were reported.
RESULTS: Thermal-ablation was used to achieve local control of 41 VMs in 28 patients. Median post-treatment follow-up was 22 months [range: 12-80] and the mean delay for first post-operative imaging was 2 months [range: 0.6-7.5]. Local control at first post-operative imaging, 12 and 24 months was achieved in 87.8%, 82.9% and 75.6%, respectively. Among the treated VMs the rates of VRE was 7.3% at 2 years, significantly lower if local control was achieved at first post-operative imaging than if it was not (0% vs 30%, p = 0.011, OR = 0.184 [95%CI = 0.094-0.360]). After thermal-ablation procedures, 19 news VMs occurred in 11 patients (39.2%) with a median interval of 8 months [range 1-26] and remained untreated. Among these untreated VMs, the rate of VREs at 2 years was significantly higher compared to the treated VMs: (36.8% vs. 7.3%, p = 0.008, OR = 0.135, [95%CI = 0.030-0.607]).
CONCLUSION: local tumor control of VMs using thermal-ablation decreases the risk of VREs in DTC patients.
引用
- Barat M, Tselikas L, de Baère T, et al. Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma. Eur J Radiol. 2019. PMID: 31525680. doi:10.1016/j.ejrad.2019.108650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。